PIEZO Force Sensors and the Heart
- PMID: 40721314
- PMCID: PMC7617987
- DOI: 10.1101/cshperspect.a041806
PIEZO Force Sensors and the Heart
Abstract
The PIEZO1 and PIEZO2 membrane proteins form uniquely structured calcium permeable nonselective cation channels dedicated to mechanical force sensing in eukaryotic cells. In this review of the scientific literature, we address PIEZOs in the heart. PIEZOs enable the formation of the aortic valve, cardiac vasculature, and pericardial drainage. In the established heart, they enable baroreceptor pressure sensing and reflex regulation of the heart rate and influence the heart's size and stiffness through roles in cardiac myocytes and cardiac fibroblasts. Therefore, mechanical force sensing by PIEZOs participates in normal cardiac development and function. There is also interest in PIEZOs in pathophysiology, when the structure and mechanical properties of the heart often change. Studies in rats and mice suggest that experimentally induced cardiac stress and injury cause PIEZO upregulation that is adverse. Similar changes may occur in human heart disease, creating potential for therapeutic benefit through PIEZO modulation. This is a productive, accelerating, and exciting new research topic with importance for our understanding of the heart and its diseases.
Copyright © 2025 Cold Spring Harbor Laboratory Press; all rights reserved.
Conflict of interest statement
Conflicts of Interest
D.J.B. is a partner of CalTIC GmbH, a pharmaceutical start-up company with a mission to develop TRPC antagonists as a new class of medicines for the treatment of metabolic disease/obesity and pathological cardiac remodeling. K.M.H. is an employee and shareholder of Novo Nordisk A/S. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed.
Figures
References
-
- Balaban RS. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J Mol Cell Cardiol. 2002;34:1259–1271. - PubMed
-
- Baratchi S, Zaldivia MTK, Wallert M, Loseff-Silver J, Al-Aryahi S, Zamani J, Thurgood P, Salim A, Htun NM, Stub D, et al. Transcatheter aortic valve implantation represents an anti-inflammatory therapy via reduction of shear stress-induced, Piezo-1-mediated monocyte activation. Circulation. 2020;142:1092–1105. - PubMed
-
- Bartoli F, Debant M, Chuntharpursat-Bon E, Evans EL, Musialowski KE, Parsonage G, Morley LC, Futers TS, Sukumar P, Bowen TS, et al. Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity. J Clin Invest. 2022a;132:e141775. doi: 10.1172/JCI141775. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources